Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. João (são paulo, Brazil), J. Barbosa (são paulo, Brazil), L. Da Silva (são paulo, Brazil), T. Dos Santos (são paulo, Brazil), L. Camargo (são paulo, Brazil), E. De Campos (são paulo, Brazil), T. Galil (são paulo, Brazil), B. Saraiva- Romanholo (são paulo, Brazil), S. Bezerra (são paulo, Brazil), S. Hamaguchi (são paulo, Brazil), M. Martins (são paulo, Brazil), M. Olivo (são paulo, Brazil), R. Righetti (são paulo, Brazil), I. Tibério (são paulo, Brazil), E. Leick (são paulo, Brazil). Plant protease inhibitors compared to corticosteroids in mice with Asthma-COPD. 3306

Member's Comments

No comment yet.

Related content which might interest you: Specific NFKappaB and Rho-Quinase inhibitors compared to corticosteroid in asthma model in mice Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Plant proteinase inhibitor from bauhinia bauhinioides attenuates elastase-induced emphysema in mice Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Treatment with proteinase inhibitor from Enterolobium contortisiliquum in mice with asthma-COPD Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Fast, efficient and realistic in vitro delivery of inhaled drugs to pulmonary cells: Application to the proteasome inhibitor bortezomib Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Tolerance to COX-2 inhibitors in patients intolerant to aspirin: challenge mandatory Source: Eur Respir J 2003; 22: Suppl. 45, 547s Year: 2003 Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Effect of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor (PDE4i) on markers of inflammation in COPD patients Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 JAK inhibitors overcome corticosteroid insensitivity in COPD Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 RP6503, a novel and selective PI3K δ/gamma inhibitor, potentiates the effect of steroids in pre-clinical models of COPD Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Newer immunosuppressants: MMF and mTor inhibitors Source: School Course 2012 - Lung Transplantation Year: 2012 Plant proteinase inhibitor from enterolobium contortisiliquum (EcTI) attenuates elastase-induced pulmonary inflammatory and remodeling alterations in mice Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Pirfenidone, proton pump inhibitor, N acetyl cysteine (PINPOINT) therapy for IPF: Tolerance and safety profile among Indian patients Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Macrophage chromatin condition and protease inhibitor activity studying in brush-biopsies at patients with infectious COPD exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 In vitro pharmacological characterization of CHF6001, a novel selective phosphodiesterase 4 (PDE4) inhibitor with a robust anti-inflammatory profile Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016